Qiuran Xu Selected Research

Qiuran Xu Research Topics

Disease

35	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 11/2010
33	Neoplasms (Cancer) 01/2024 - 11/2010
14	Neoplasm Metastasis (Metastasis) 01/2024 - 11/2010
9	Hypoxia (Hypoxemia) 01/2022 - 01/2019
4	Inflammation (Inflammations) 04/2022 - 01/2021
3	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2021
3	Liver Neoplasms (Liver Cancer) 01/2022 - 01/2018
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2019
3	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2020
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 11/2019
3	Carcinogenesis 11/2020 - 11/2014
3	Lung Neoplasms (Lung Cancer) 01/2020 - 02/2019
3	Glioma (Gliomas) 09/2019 - 11/2010
2	Colitis 01/2023 - 04/2022
2	Colonic Neoplasms (Colon Cancer) 10/2022 - 01/2022
2	Ulcerative Colitis 03/2022 - 02/2022
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2021 - 01/2021
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2020 - 01/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 12/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024
1	Reperfusion Injury 12/2023
1	Digestive System Neoplasms (Cancer of the Digestive System) 01/2023
1	Wounds and Injuries (Trauma) 04/2022
1	Dysbiosis 02/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Pathologic Processes 01/2022
1	Complementation Group C Xeroderma Pigmentosum 01/2021

Drug/Important Bio-Agent (IBA)

12	Long Noncoding RNAIBA 01/2024 - 01/2019
8	MicroRNAs (MicroRNA)IBA 07/2023 - 12/2017
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2017
7	Proteins (Proteins, Gene)FDA Link 03/2024 - 11/2010
5	Messenger RNA (mRNA)IBA 01/2024 - 11/2010
3	Deubiquitinating EnzymesIBA 04/2024 - 01/2021
3	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2021
3	EnzymesIBA 01/2023 - 01/2021
3	CytokinesIBA 04/2022 - 01/2021
2	Oxygen (Dioxygen)IBA 12/2023 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 01/2023
2	lenvatinibIBA 10/2023 - 01/2022
2	Co-Repressor ProteinsIBA 07/2023 - 07/2018
2	Ubiquitin-Conjugating EnzymesIBA 05/2023 - 01/2021
2	Protein Hydrolysates FDA Link 01/2023 - 11/2018
2	Oviductus RanaeIBA 01/2023 - 11/2018
2	polydopamineIBA 10/2022 - 01/2022
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2022 - 03/2018
2	LipopolysaccharidesIBA 04/2022 - 02/2022
2	TNF Receptor-Associated Factor 4IBA 01/2022 - 01/2018
2	Ubiquitin-Specific ProteasesIBA 01/2022 - 01/2020
2	ChromatinIBA 01/2021 - 01/2019
2	Histones (Histone)IBA 01/2021 - 01/2021
2	Pyruvate KinaseIBA 12/2017 - 11/2014
1	UbiquitinIBA 03/2024
1	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2024
1	Insulin-Like PeptidesIBA 01/2024
1	Sincalide FDA Link 01/2024
1	Carrier Proteins (Binding Protein)IBA 01/2024
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2024
1	Free RadicalsIBA 12/2023
1	CarbonIBA 12/2023
1	Type 4 Fibroblast Growth Factor ReceptorIBA 12/2023
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2023
1	Immune Checkpoint InhibitorsIBA 12/2023
1	Amino Acids FDA Link 10/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023
1	Dextran SulfateIBA 01/2023
1	Antisense RNA (Anti-Sense RNA)IBA 10/2022
1	Interleukin-6 (Interleukin 6)IBA 04/2022
1	AntioxidantsIBA 04/2022
1	CurcuminIBA 04/2022
1	LuminolIBA 03/2022
1	PolymersIBA 03/2022
1	AlginatesIBA 02/2022
1	BerberineIBA 02/2022
1	HydrogelsIBA 02/2022
1	Small Interfering RNA (siRNA)IBA 02/2022
1	ChitosanIBA 02/2022
1	ProteomeIBA 01/2022
1	6-methyladenineIBA 01/2022
1	CatalaseIBA 01/2022
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022
1	N-methyladenosineIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 12/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2021
1	Conditioned Culture MediaIBA 12/2021
1	DNA (Deoxyribonucleic Acid)IBA 08/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Prolyl-Hydroxylase InhibitorsIBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	histone deacetylase 3IBA 01/2021

Therapy/Procedure

11	Therapeutics 12/2023 - 03/2020
3	Immunotherapy 01/2024 - 01/2022
3	Radiotherapy 01/2023 - 01/2022
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2021
1	Liver Transplantation 12/2023
1	Oral Administration 04/2022
1	Precision Medicine 03/2022
1	Neoadjuvant Therapy 01/2022
1	Photochemotherapy (Photodynamic Therapy) 01/2022